Harnessing the power of antibodies to fight bone metastasis

Simple item page
dc.citation.articleNumbereabf2051
dc.citation.issueNumber26
dc.citation.journalTitleScience Advances
dc.citation.volumeNumber7
dc.contributor.authorTian, Zeru
dc.contributor.authorWu, Ling
dc.contributor.authorYu, Chenfei
dc.contributor.authorChen, Yuda
dc.contributor.authorXu, Zhan
dc.contributor.authorBado, Igor
dc.contributor.authorLoredo, Axel
dc.contributor.authorWang, Lushun
dc.contributor.authorWang, Hai
dc.contributor.authorWu, Kuan-Lin
dc.contributor.authorZhang, Weijie
dc.contributor.authorZhang, Xiang H.-F.
dc.contributor.authorXiao, Han
dc.date.accessioned2021-07-08T13:46:02Z
dc.date.available2021-07-08T13:46:02Z
dc.date.issued2021
dc.description.abstractAntibody-based therapies have proved to be of great value in cancer treatment. Despite the clinical success of these biopharmaceuticals, reaching targets in the bone microenvironment has proved to be difficult due to the relatively low vascularization of bone tissue and the presence of physical barriers. Here, we have used an innovative bone-targeting (BonTarg) technology to generate a first-in-class bone-targeting antibody. Our strategy involves the use of pClick antibody conjugation technology to chemically couple the bone-targeting moiety bisphosphonate to therapeutic antibodies. Bisphosphonate modification of these antibodies results in the delivery of higher conjugate concentrations to the bone metastatic niche, relative to other tissues. In xenograft mice models, this strategy provides enhanced inhibition of bone metastases and multiorgan secondary metastases that arise from bone lesions. Specific delivery of therapeutic antibodies to the bone, therefore, represents a promising strategy for the treatment of bone metastatic cancers and other bone diseases. Precision modification of antibodies with bone-targeting moieties unleashes their potential for the treatment of bone metastases. Precision modification of antibodies with bone-targeting moieties unleashes their potential for the treatment of bone metastases.
dc.identifier.citationTian, Zeru, Wu, Ling, Yu, Chenfei, et al.. "Harnessing the power of antibodies to fight bone metastasis." <i>Science Advances,</i> 7, no. 26 (2021) AAAS: https://doi.org/10.1126/sciadv.abf2051.
dc.identifier.digitaleabf2051-full
dc.identifier.doihttps://doi.org/10.1126/sciadv.abf2051
dc.identifier.urihttps://hdl.handle.net/1911/111000
dc.language.isoeng
dc.publisherAAAS
dc.rightsThis is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license, which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.titleHarnessing the power of antibodies to fight bone metastasis
dc.typeJournal article
dc.type.dcmiText
dc.type.publicationpublisher version
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
eabf2051-full.pdf
Size:
2.64 MB
Format:
Adobe Portable Document Format
Download
Collections
Faculty Publications
Bioengineering Publications
BioSciences Publications
Chemistry Publications